Dr. Alexander Jorge Bandin, MD

Dr. Bandin practices at New Mexico Surgery Center Multi-Specialty - Albuquerque in Albuquerque, New Mexico.

Dr. Bandin's NPI, 1790149433, was assigned on April 8, 2016. Dr. Bandin graduated from Columbia University College of Physicians and Surgeons in 2016. Dr. Bandin holds Connecticut license 067992.

Dr. Bandin's primary practice is New Mexico Surgery Center Multi-Specialty - Albuquerque, at 201 Cedar St Se, Suite 7650, Albuquerque, NM 87106. The practice phone is (505) 317-9444.

Dr. Bandin's primary practice is New Mexico Surgery Center Multi-Specialty - Albuquerque in Albuquerque, New Mexico. Dr. Bandin is also affiliated with Presbyterian Hospital. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Bandin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bandin practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Bandin's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Bandin is licensed in Connecticut.

CMS data shows 359 Medicare services from Dr. Bandin across 11 procedure codes in 2024, for 181 Medicare patients. Medicare paid $28,909 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 181 Medicare patients who saw Dr. Bandin in 2024. The largest group is 65 to 74, with 85 patients. 72% of them have high cholesterol, and 69% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bandin's median patient age at 68, with 22% women.

In 2024, Dr. Bandin wrote 656 Medicare Part D claims for 219 patients. 95% of them were for generic drugs. CMS names the drug for 574 of them, across 11 drugs with 11 or more claims each, at $23,915 in total drug cost. In 2023, CMS named 458 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Bandin for performance year 2024, reported as part of a group. Dr. Bandin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bandin as offering telehealth. CMS counts 21 procedures of prostate resection by Dr. Bandin, more than 83% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 40 general payments to Dr. Bandin from 18 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 51% of the total. PROCEPT BioRobotics Corporation paid the most, $1,231.

Dr. Bandin graduated from Columbia University College of Physicians and Surgeons in 2016.